Probiotics: an overview of beneficial effects

Abstract

Food products fermented by lactic acid bacteria have long been used for their proposed health promoting properties. In recent years, selected probiotic strains have been thoroughly investigated for specific health effects. Properties like relief of lactose intolerance symptoms and shortening of rotavirus diarrhoea are now widely accepted for selected probiotics. Some areas, such as the treatment and prevention of atopy hold great promise. However, many proposed health effects still need additional investigation. In particular the potential benefits for the healthy consumer, the main market for probiotic products, requires more attention. Also, the potential use of probiotics outside the gastrointestinal tract deserves to be explored further. Results from well conducted clinical studies will expand and increase the acceptance of probiotics for the treatment and prevention of selected diseases.

This is a preview of subscription content, log in to check access.

References

  1. Aso Y, Akaza H, Kotake T, Tsukamoto T, Imai K, Naito S&BLP Study Group (1995) Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. Eur. J. Urol. 27: 104–109.

    Google Scholar 

  2. Barefoot SF&Ratnam P (1998) Composition for treating acne. US patent WO98/10743.

  3. Benno Y, Mitsuoka T& Kanazawa K (1991) Human faecal flora in health and colon cancer. Acta Chirurgica Scand. 521: 15–23.

    Google Scholar 

  4. Benno Y, He F, Hosoda M, Hashimoto H, Kojima T, Yamazaki K, Iino H, Mykkänen H& Salminen S (1996) Effects of Lactobacillus GG yogurt on human intestinal microecology in Japanese subjects. Nutrition Today 31: 9S-11S.

    Google Scholar 

  5. Black FT, Andersen PL, Örsskov J, Örskov F, Gaarslev K& Laulund S (1989) Prophylactic efficacy of lactobacilli on travelers diarrhea. Travel Med. 7: 333–335.

    Google Scholar 

  6. Black F, Einarsson K, Lidbeck A, Orrhage K& Nord CE (1991) Effect of lactic acid producing bacteria on the human intestinal microflora during ampicillin treatment. Scand. J. Infect. Dis. 2: 247–254.

    Google Scholar 

  7. Brandtzaeg P (1995) Molecular and cellular aspects of the secretory immunoglobulin system. APMIS 103: 1–19.

    Google Scholar 

  8. Brigidi P, Vitali B, Swennen E, Bazzocchi G& Matteuzzi D (2001) Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiotia in patients with irritable bowel syndrome or functional diarrhea. Res. Microbiol. 152: 735–741.

    Google Scholar 

  9. Bunthof CJ, Bloemen K, Breeuwer P, Rombouts FM& Abee T (2001) Flow cytometric assessment of viability of lactic acid bacteria. Appl. Environ. Microbiol. 67: 2326–2335.

    Google Scholar 

  10. Cangemi de Gutierrez R, Santos V& Nader-Macías, ME (2001) Protective effect of intranasally inocculated Lactobacillus fermentum against Streptococcus pneumoniae challenge on the mouse respiratory tract. FEMS Immunol. Med. Microbiol. 31: 187–195.

    Google Scholar 

  11. Claeson M& Merson MH (1990) Global progress in the control of diarrheal disease. Pediatr. Infect. Dis. J. 9: 345–355.

    Google Scholar 

  12. Ducroc R, Heyman M, Beaufrere B, Morgat JL& Desjeux JF (1983) Horseradish peroxidase transport across rabbit jejunum and Peyer's patches in vitro. Am. J. Physiol. 245: G54–G58.

    Google Scholar 

  13. Elo S, Saxelin M& Salminen S (1991) Attachment of Lactobacillus casei strain GG to human colon carcinoma cell line Caco-2: comparison with other dairy strains. Lett. Appl. Microbiol. 13: 154–156.

    Google Scholar 

  14. Felley CP, Corthesy-Theulaz I, Rivero JL, Sipponen P, Kaufmann M, Bauerfeind P, Wiesel PH, Brassart D, Pfeifer A, Blum AL& Michetti P (2001) Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man. Eur. J. Gastroenterol. Hepatol. 13: 25–29.

    Google Scholar 

  15. Fuller R (1989) Probiotics in man and animals. J. Appl. Bacteriol. 66: 365–378.

    Google Scholar 

  16. Gill HS& Rutherfurd KJ (2001) Probiotic supplementation to enhance natural immunity in the elderly: effects of a newly characterized immunomodulatory strain Lactobacillus rhamnosus HN001 (DR20™) on leucocyte phagocytosis. Nutr. Res. 21: 183–189.

    Google Scholar 

  17. Gismondo MR, Drago L& Lombardi A (1999) Review of probiotics available to modify gastrointestinal flora. Int. J. Antimicrobial Agents 12: 287–292.

    Google Scholar 

  18. Goldin BR (1998) Health benefits of probiotics. Br. J. Nutr. 80: S203–S207.

    Google Scholar 

  19. Greenwald P, Clifford CK& Milner JA (2001) Diet and cancer prevention. Eur. J. Cancer 37: 948–965.

    Google Scholar 

  20. Grönlund MM, Arvilommi H, Kero P, Lehtonen OP& Isolauri E (2000) Importance of intestinal colonisation in the maturation of humoral immunity in early infancy: a prospective follow up study of healthy infants aged 0-6 months. Arch. Dis. Childhood 83: F186–F192.

    Google Scholar 

  21. Groux H& Powrie F (1999) Regulatory T cells and inflammatory bowel disease. Immunol. Today 20: 442–446.

    Google Scholar 

  22. Guandalini S, Pensabene L, Zikri MA, Dias JA, Casali LG, Hoekstra H, Kolacek S, Massar K, Micetic-Turk D, Papadopoulou A, de Sousa JS, Sandhu B, Szajewska H& Weizman Z (2000) Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J. Ped. Gastroenterol. Nutr. 30: 54–60.

    Google Scholar 

  23. Guarner F& Schaafsma GJ (1998) Probiotics. Int. J. Food Microbiol. 39: 237–238.

    Google Scholar 

  24. Gupta P, Andrew H, Kirschner BS& Guandalini S (2000) Is Lactobacillus GG helpful in children with Crohn's disease? Results of a preliminary, open-label study. J. Ped. Gastroenterol. Nutr. 31: 453–457.

    Google Scholar 

  25. Guslandi M, Mezzi G, Sorghi M& Testoni PA (2000) Saccharomyces boulardii in maintenance treatment of Crohn's disease. Digestive Dis. Sci. 45: 1462–1464.

    Google Scholar 

  26. Haller D, Bode C, HammesWP, Pfeifer AMA, Schiffrin EJ& Blum S (2000) Non-pathogenic bacteria elicit differential cytokine response by intestinal epithelial cell/Leukocyte co-cultures. Gut 47: 79–87.

    Google Scholar 

  27. Hamilton-Miller JMT (2001) A review of clinical trials of probiotics in the management of inflammatory bowel diesease. Infect. Dis. Rev. 3: 83–87.

    Google Scholar 

  28. Hamilton-Miller JMT& Shah S (2002) Deficiencies in microbiological quality and labellinf of probiotic supplements. Int. J. Food Microbiol. 72: 175–176.

    Google Scholar 

  29. Hatakka K, Savilahti E, Pönkä A, Meurman JH, Poussa T, Näse L, Saxelin M& Korpela R (2001) Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind randomised trial. Br. Med. J. 322: 1327–1329.

    Google Scholar 

  30. Helgeland L, Vaage JT, Rolstad B, Midtvedt T& Brandtzaeg P (1996) Microbial colonization influences composition and T-cell receptor V beta repertoire of intraepithelial lymphocytes in rat intestine. Immunology 89: 494–501.

    Google Scholar 

  31. Heyman M& Desjeux JF (2000) Cytokine-induced alteration of the epithelial barrier to food antigens in disease. Ann. NY Acad. Sci. 915: 304–311.

    Google Scholar 

  32. Hilton E, Isenberg HD, Alperstein P, France K& Borenstein MT (1992) Ingestion of yoghurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann. Int. Med. 116: 353–357.

    Google Scholar 

  33. Hirayama K& Rafter J (2000) The role of probiotic bacteria in cancer prevention. Microbes Infect. 2: 681–686.

    Google Scholar 

  34. Isolauri E (1999) Probiotics and gut inflammation. Curr. Opin. Gastroenterol. 15: 534–537.

    Google Scholar 

  35. Isolauri E (2001) Probiotics in human disease. Am. J. Clin. Nutr. 73: S1142–S1146.

    Google Scholar 

  36. Isolauri E, Kaila M, Arvola T, Majamaa H, Rantala I, Virtanen E& Arvilommi H (1993) Diet during rotavirus enteritis affects jejunal permeability to macromolecules in suckling rats. Ped. Res. 33: 548–553.

    Google Scholar 

  37. Isolauri E, Arvola T, Sütas Y, Moilanen E& Salminen S (2000) Probiotics in the management of atopic eczema. Clin. Exp. Allergy 30: 1605–1610.

    Google Scholar 

  38. Isolauri E, Sütas Y, Kankaanpää P, Arvilommi H& Salminen S (2001) Probiotics: effects on immunity. Am. J. Clin. Nutr. 73: S444–S445.

    Google Scholar 

  39. Kaila M, Isolauri E, Soppi E, Virtanen E, Laine S& Arvilommi H (1992) Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Ped. Res. 32: 141–144.

    Google Scholar 

  40. Kaila M, Isolauri E, Saxelin M, Arvilommi H& Veskari T (1995) Viable versus inactivated Lactobacillus strain GG in acute rotavirus diarrhoea. Arch. Dis. Childhood 72: 51–53.

    Google Scholar 

  41. Kalliomäki M, Kirjavainen P, Eerola E, Kero P, Salminen S& Isolauri E (2001a) Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J. Allergy Clin. Immunol. 107: 129–134.

    Google Scholar 

  42. Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P& Isolauri E (2001b) Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357: 1076–1079.

    Google Scholar 

  43. Lasser RB, Bond JH& Levitt MD (1975) The role of intestinal gas in functional abdominal pain. New Engl. J. Med. 293: 524–526.

    Google Scholar 

  44. Launiala K (1968) The effect of unabsorbed sucrose and mannitol on the small intestinal flow rate and mean transit time. Scand. J. Gastroenterol. 3: 665–671.

    Google Scholar 

  45. Lee Y-K, Nomoto K, Salminen S& Gorbach SL (1999) Handbook of Probiotics. John Wiley&Sons, Inc., New York.

    Google Scholar 

  46. Link-Amster H, Rochat F, Saudan KY, Mignot O, Aeschlimann JM (1994) Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented mik intake. FEMS Immunol. Med. Microbiol. 10: 55–64.

    Google Scholar 

  47. MacDonald T (2001) The reaction of the immune system to pathogens but not food antigens and commensal bacteria. Seminars Immunol. 13: 159–161.

    Google Scholar 

  48. Majamaa H& Isolauri E (1997) Probiotics: a novel approach in the management of food allergy. J. Allergy Clin. Immunol. 99: 179–186.

    Google Scholar 

  49. Malchow HA (1997) Crohn's disease and Echerichia coli. J. Clin. Gastroenterol. 25: 653–658.

    Google Scholar 

  50. Mattila-Sandholm T, Blum S, Collins JK, Crittenden R, de Vos W, Dunne C, Fondén R, Grenov G, Isolauri E, Kiely B, Marteau P, Morelli L, Ouwehand A, Reniero R, Saarela M, Salminen S, Saxelin M, Schiffrin E, Shanahan F, Vaughan E& von Wright A (1999) Probiotics: towards demonstrating efficacy. Trends Food Sci. Technol. 10: 393–399.

    Google Scholar 

  51. Meurman JH, Antila H& Salminen S (1994) Recovery of Lactobacillus strain GG (ATCC 53103) from saliva of healthy volunteers after consumption of yoghurt prepared with the bacterium. Microbial Ecol. Health Dis. 7: 295–298.

    Google Scholar 

  52. Nagao F, Nakayama M, Muto T& Okumura K (2000) Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the immune system in healthy human subjects. Biosci. Biotechnol. Biochem. 64: 2706–2708.

    Google Scholar 

  53. Niedzielin K, Kordecki H& Birkenfeld B (2001) A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299v in patients with irritable bowel syndrome. Eur. J. Gastroenterol. Hepatol. 13: 1143–1147.

    Google Scholar 

  54. Ouwehand AC& Salminen SJ (1998) The health effects of cultured milk products with viable and non-viabel bacteria. Int. Dairy J. 8: 749–758.

    Google Scholar 

  55. Ouwehand AC, Isolauri E, Kirjavainen PV& Salminen SJ (1999) Adhesion of four Bifidobacterium strains to human intestinal mucus from subjects in different age groups. FEMS Microbiol. Lett. 172: 61–64.

    Google Scholar 

  56. Ouwehand AC, Tölkkö S& Salminen S (2001) The effect of digestive enzymes on the adhesion of probiotic bacteria in vitro. J. Food Sci. 66: 856–859.

    Google Scholar 

  57. Ouwehand AC, Salminen S, Tölkkö S, Roberts PJ, Ovaska J&Salminen E (2002) Disease dependent adhesion of lactic acid bacteria to colonic tissue in vitro. Microecol. Ther. In press.

  58. Pessi T, Isolauri E, Sütas Y, Kankaanranta H, Moilanen E& Hurme M (2000a) Suppression of T cell activation by Lactobacillus rhamnosus GG-degraded bovine casein. Immunopharmacology 1: 211–218.

    Google Scholar 

  59. Pessi T, Sütas Y, Hurme M& Isolauri E (2000b) Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin. Exp. Allergy 30: 1804–1808.

    Google Scholar 

  60. Petti S, Tarsitani G& Simonetti D'Arca A (2001) A randomized clinical trial of the effect of yoghurt on the human salivary microflora. Arch. Oral Biol. 46: 705–712.

    Google Scholar 

  61. Redondo-Lopez V, Cook RL& Sobel JD (1990) Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora. Rev. Infect. Dis. 12: 856–872.

    Google Scholar 

  62. Reid G, Bruce AW& Taylor M (1992) Influence of three day antimicrobial therapy and Lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clin. Therapy 14: 11–16.

    Google Scholar 

  63. Reid G (2001) Probiotic agents to protect the urogenital tract against infection. Am. J. Clin. Nutr. 73: 437S–443S.

    Google Scholar 

  64. Reid G, Bruce AW, Fraser N, Heinemann C, Owen J& Henning B (2001) Oral probiotics can resolve urogenital infections. FEMS Immunol. Med. Microbiol. 30: 49–52.

    Google Scholar 

  65. Saavedra JM, Bauman NA, Oung I, Perman JA& Yolken RH (1994) Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 344: 1046–1049.

    Google Scholar 

  66. Salim AF, Phillips AD& Farthing MJ (1990) Pathogenesis of gut virus infection. Baillières Clin. Gastroenterol. 4: 593–607.

    Google Scholar 

  67. Salminen S, Isolauri E& Salminen E (1996) Clinical uses of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges. Antonie Van Leeuwenhoek 70: 347–358.

    Google Scholar 

  68. Salminen S, Bouley C, Boutron-Ruault M-C, Cummings JH, Franck A, Gibson GR, Isolauri E, Moreau M-C, Roberfroid M& Rowland I (1998) Functional food science and gastrointestinal physiology and function. Br. J. Nutr. 80: S147–S171.

    Google Scholar 

  69. Salminen S, Ouwehand A, Benno Y& Lee YK (1999) Probiotics: how should they be defined? Trends Food Sci. Technol. 10: 107–110.

    Google Scholar 

  70. Sanderson IR& Walker WA (1993) Uptake and transport of macromolecules by the intestine: possible role in clinical disorders (an update). Gastroenterology 104: 622–639.

    Google Scholar 

  71. Shimoyama T, Hori S, Tamura K, Yamamura M, Tanaka M& Yamazaki K (1984) Microflora of patients with stool abnormality. Bifidobacteria and Microflora 3: 35–42.

    Google Scholar 

  72. Shornikova A-V, Casas I, Mykkänen H, Salo E& Vesikari T (1997) Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Ped. Infect. Dis. J. 16: 1103–1107.

    Google Scholar 

  73. Spanhaak S, Havenaar R& Schaafsma G (1998) The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans. Eur. J. Clin. Nutr. 52: 899–907.

    Google Scholar 

  74. Strachan DP (1989) Hay fever, hygiene, and household size. Br. Med. J. 299: 1259–1260.

    Google Scholar 

  75. Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C& Koga Y (1997) The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J. Immunol. 159: 1739–1745.

    Google Scholar 

  76. Sugita T& Togawa M (1994) Efficacy of Lactobacillus preparation Biolactis powder in children with rotavirus enteritis. Jpn. J. Pediatr. 47: 2755–2762.

    Google Scholar 

  77. Surawicz CM, Elmer GW, Spleeman P, McFarland LV, Chinn J& van Belle G (1989) Prevention of antibiotic associated diarrhoea by Saccharomyces boulardii: a prospective study. Gastroenterology 96: 981–988.

    Google Scholar 

  78. Sütas Y, Hurme M& Isolauri E (1996) Downregulation of antiCD3 antibody-induced IL-4 production by bovine caseins hydrolysed with Lactobacillus GG-derived enzymes. Scand. J. Immunol. 43: 687–689.

    Google Scholar 

  79. Temmerman R, Huys G, Pot B&Swings J (2001) Identification and antibiotic resistance of isolates from probiotic products. Abstracts of 101st ASM General Meeting, C–289.

  80. Tuomola EM, Ouwehand AC& Salminen SJ (2000) Chemical, physical and enzymatic pre-treatments of probiotic lactobacilli alter their adhesion to human intestinal mucus glycoproteins. Int. J. Food Microbiol. 60: 75–81.

    Google Scholar 

  81. Tuomola E, Crittenden R, Playne M, Isolauri E& Salminen S (2001) Quality assurence criteria for probiotic bacteria. Am. J. Clin. Nutr. 73: S393–S398.

    Google Scholar 

  82. Vesa T, Marteau P& Korpela R (2000) Lactose intolerance. J. Am. Coll. Nutr. 19: 165S–175S.

    Google Scholar 

  83. Virta M, Lineri S, Kankaanpää P, Karp M, Peltonen K, Nuutila J& Lilius E-M (1998) Determination of complement-mediated killing of bacteria by viability staining and bioluminescence. Appl. Environ. Microbiol. 64: 515–519.

    Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Arthur C. Ouwehand.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ouwehand, A.C., Salminen, S. & Isolauri, E. Probiotics: an overview of beneficial effects. Antonie Van Leeuwenhoek 82, 279–289 (2002). https://doi.org/10.1023/A:1020620607611

Download citation

  • health effects
  • lactic acid bacteria
  • probiotics